LSI, a global specialty chemicals business with leading positions in Microbial Control Solutions (‘MCS’) and Specialty Products Solutions (‘SPS’), recently announced that it has rebranded as Arxada, effective from 21 October 2021. The new name follows the Company’s launch as an independent business in July 2021, after the completion of the sale of Lonza Specialty Ingredients from Lonza Group.
Commenting on the new company name, Marc Doyle, Chief Executive Officer of Arxada, said: “This new identity signals our intent to transform the Company as we build on our longstanding heritage of innovation and pioneering technology to enhance our presence within the microbial control and specialty chemicals markets. Our new corporate identity demonstrates our commitment to enable our customers and their products to be more efficient, more effective, more responsible and more sustainable.”
The re-brand reflects the Company’s passion for delivering high performance and realizing potential, both for its customers and within its own operations. Arxada’s industry-leading regulatory expertise and deep understanding of each customer’s markets and evolving requirements, combined with its broad portfolio of science and technology capabilities, enable it to provide customized solutions which help customers perform at their best.
The name Arxada derives from arx and arcis, the Latin words for citadel and fortress. In the same way that a citadel acts as a stronghold or protector, Arxada provides solutions that strengthen the performance of its customers and their products, and help to protect people, places and the planet.
Arxada, formerly part of Lonza Group, is a global specialty chemicals business with leading positions in Microbial Control Solutions (‘MCS’) and Specialty Products Solutions (‘SPS’). Arxada provides a broad portfolio of differentiated products targeted at a range of end markets, supported by its leading regulatory capabilities, IP expertise, and established track record in R&D.
Arxada’s MCS business is a world leader addressing six target markets: hygiene, home and personal care, paints and coatings, crop protection, material protection and wood protection. MCS is built on industry-leading regulatory expertise, the broadest set of bioactives and the widest range of registrations in the world, which are critical to maintaining the integrity of its customers’ products.
Arxada’s unique SPS business provides complex, high-quality technologies and chemistries to customers across a range of industries within its three divisions: performance intermediates and chemicals, composite materials, and the custom development and manufacturing organisation. The two businesses work closely together to provide complementary expertise and deliver unique, innovative solutions to help customers protect their products from harmful microorganisms, improve health and safety and reduce their environmental footprints.
Arxada has a global footprint spanning 32 countries across five continents. Its world-leading team of around 2,900 employees serve over 5,000 customers across a wide range of industries. Arxada is owned by Bain Capital Private Equity and Cinven.